4//SEC Filing
Rosol Michael Stanley 4
Accession 0001437749-21-003111
CIK 0000810509other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:11 PM ET
Size
5.9 KB
Accession
0001437749-21-003111
Insider Transaction Report
Form 4
Rosol Michael Stanley
Chief Medical Officer
Transactions
- Award
Stock Option
2021-02-15$0.00/sh+25,000$25→ 25,000 totalExercise: $2.56Exp: 2031-02-15→ Common Stock (25,000 underlying)
Holdings
- 6,816(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]Stock options granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan, which vest as to one-third on each of the first three anniversaries of the date of grant.
Documents
Issuer
NAVIDEA BIOPHARMACEUTICALS, INC.
CIK 0000810509
Entity typeother
Related Parties
1- filerCIK 0001762349
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 4:11 PM ET
- Size
- 5.9 KB